Abstract
Purpose
It is important to take into account potential prognostic factors to select patients with brain metastasis from colorectal cancer (CRC) who will benefit from active neurosurgical treatment. Therefore, we experimentally investigated our single institutional data to develop a novel CRC-specific graded prognostic assessment (GPA) and to help clinicians determine the optimal management.
Methods and materials
We retrospectively reviewed the records of 107 patients with brain metastases from CRC who received any kind of treatment in our hospital and had sufficient clinical information.
Results
The median overall survival was 5.2 months, and the 1- and 2-year overall survival rates were 23.7 and 6.6%, respectively. Multivariate analysis revealed that the number of brain metastases ≥ 6, presence of neurologic symptoms, and elevated serum carcinoembryonic antigen (≥ 30 ng/ml) were the independent prognostic factors for poor overall survival, while performance status was not. Based on this, we developed the CRC-specific GPA index and stratified patients into three categories. The median overall survival for patients with GPA scores of 0–0.5, 1.0–1.5, and 2.0–2.5 was 2.3, 4.3, and 12.7 months, respectively (p < 0.001). Surgery or stereotactic radiosurgery ± whole-brain radiotherapy showed a better survival than palliative whole-brain radiotherapy alone in patients with high GPA scores.
Conclusions
We developed a novel CRC-specific GPA index, which could help physicians to stratify patients with brain metastases. Further efforts are needed to validate and improve this index.
Similar content being viewed by others
References
Ferlay J, Soerjomataram I, Dikshit R et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136:E359–E386. https://doi.org/10.1002/ijc.29210
Jung K-W, Won Y-J, Oh C-M et al (2017) Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2014. Cancer Res Treat 49:292–305. https://doi.org/10.4143/crt.2017.118
Christensen TD, Spindler K-LG, Palshof JA et al (2016) Systematic review: brain metastases from colorectal cancer—incidence and patient characteristics. BMC Cancer 16:260. https://doi.org/10.1186/s12885-016-2290-5
Christensen TD, Palshof JA, Larsen FO et al (2017) Risk factors for brain metastases in patients with metastatic colorectal cancer. Acta Oncol 56:639–645. https://doi.org/10.1080/0284186X.2017.1290272
Kim HJ, Huh JW, Jung TY et al (2013) Clinical outcome with gamma-knife surgery or surgery for brain metastases from colorectal cancer. J Clin Neurosci 20:1417–1421. https://doi.org/10.1016/j.jocn.2012.12.020
Suzuki Y, Yamaguchi T, Matsumoto H et al (2014) Prognostic factors and treatment effects in patients with curatively resected brain metastasis from colorectal cancer. Dis Colon Rectum 57:56–63. https://doi.org/10.1097/01.dcr.0000436998.30504.98
Michl M, Thurmaier J, Schubert-Fritschle G et al (2015) Brain metastasis in colorectal cancer patients: survival and analysis of prognostic factors. Clin Colorectal Cancer 14:281–290. https://doi.org/10.1016/j.clcc.2015.05.009
Weltman E, Salvajoli JV, Brandt RA et al (2000) Radiosurgery for brain metastases: a score index for predicting prognosis. Int J Radiat Oncol Biol Phys 46:1155–1161
Lorenzoni J, Devriendt D, Massager N et al (2004) Radiosurgery for treatment of brain metastases: estimation of patient eligibility using three stratification systems. Int J Radiat Oncol Biol Phys 60:218–224. https://doi.org/10.1016/j.ijrobp.2004.02.017
Sperduto PW, Berkey B, Gaspar LE et al (2008) A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 70:510–514. https://doi.org/10.1016/j.ijrobp.2007.06.074
Sperduto PW, Kased N, Roberge D et al (2012) Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol 30:419–425. https://doi.org/10.1200/JCO.2011.38.0527
Terret C, Albrand G, Moncenix G et al (2011) Karnofsky performance scale (KPS) or physical performance test (PPT)? That is the question. Crit Rev Oncol Hematol 77:142–147. https://doi.org/10.1016/j.critrevonc.2010.01.015
Abelson JS, Michelassi F, Sun T et al (2017) Simultaneous resection for synchronous colorectal liver metastasis: the new standard of care? J Gastrointest Surg 21:975–982. https://doi.org/10.1007/s11605-017-3422-1
Joo JH, Park J-H, Kim JC et al (2017) Local control outcomes using stereotactic body radiation therapy for liver metastases from colorectal cancer. Int J Radiat Oncol Biol Phys 99:876–883. https://doi.org/10.1016/j.ijrobp.2017.07.030
Al Bandar MH, Kim NK (2017) Current status and future perspectives on treatment of liver metastasis in colorectal cancer (review). Oncol Rep 37:2553–2564. https://doi.org/10.3892/or.2017.5531
Patil CG, Pricola K, Sarmiento JM et al (2017) Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases. Cochrane Database Syst Rev 9:CD006121. https://doi.org/10.1002/14651858.CD006121.pub4
Yuan X, Liu W-J, Li B et al (2017) A Bayesian network meta-analysis of whole brain radiotherapy and stereotactic radiotherapy for brain metastasis. Medicine (Baltimore) 96:e7698. https://doi.org/10.1097/MD.0000000000007698
Taylor AE, Olver IN, Sivanthan T et al (1999) Observer error in grading performance status in cancer patients. Support Care Cancer 7:332–335
Noura S, Ohue M, Shingai T et al (2012) Brain metastasis from colorectal cancer: prognostic factors and survival. J Surg Oncol 106:144–148. https://doi.org/10.1002/jso.23055
Tanriverdi O, Kaytan-Saglam E, Ulger S et al (2014) The clinical and pathological features of 133 colorectal cancer patients with brain metastasis: a multicenter retrospective analysis of the Gastrointestinal Tumors Working Committee of the Turkish Oncology Group (TOG). Med Oncol 31:152. https://doi.org/10.1007/s12032-014-0152-z
Magni E, Santoro L, Ravenda PS et al (2014) Brain metastases from colorectal cancer: main clinical factors conditioning outcome. Int J Colorect Dis 29:201–208. https://doi.org/10.1007/s00384-013-1781-y
Duffy MJ, Lamerz R, Haglund C et al (2014) Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update. Int J Cancer 134:2513–2522. https://doi.org/10.1002/ijc.28384
Nozawa H, Ishihara S, Kawai K et al (2017) Brain metastasis from colorectal cancer: predictors and treatment outcomes. Oncology. https://doi.org/10.1159/000478661
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
There were no conflict of interest related to this article.
About this article
Cite this article
Kim, B.H., Park, H.J., Kim, K. et al. Novel graded prognostic assessment for colorectal cancer patients with brain metastases. Int J Clin Oncol 23, 1112–1120 (2018). https://doi.org/10.1007/s10147-018-1329-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-018-1329-9